<DOC>
	<DOCNO>NCT01863407</DOCNO>
	<brief_summary>This study conduct determine whether Dexamethasone-Allantoin-Metronidazole ( DAM ) Solution accelerate recovery gastrointestinal function follow abdominal operation compare placebo .</brief_summary>
	<brief_title>Study Dexamethasone-Allantoin-Metronidazole ( DAM ) Solution Treatment Post-Operative Ileus ( POI )</brief_title>
	<detailed_description>Postoperative ileus ( POI ) temporary slow stop bowel function slow movement content intestine . This functional impairment persist variable duration follow surgery , usually resolve within 1 day small intestine , 1 3 day stomach 3 5 day colon . When POI persist 5 day , generally consider severe , sometimes refer complicate prolonged POI , increase risk related morbidity . This randomize , control , double-blind study design evaluate tolerability efficacy DAM solution treatment POI patient follow abdominal operation . It conduct multiple center China . A total 480 patient enrol study . Patient participation study last postoperative day 7 [ POD 7 ] , follow-up safety assessment occur 7 day operation.The treatment outcome measure include : 1 ) GI2 ( Time achieve recovery upper low GI function measure composite endpoint time first bowel movement time tolerate first solid food ) . 2 ) Time ready discharge . 3 ) Time first flatus .</detailed_description>
	<mesh_term>Ileus</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Allantoin</mesh_term>
	<criteria>either Male Female least 18 year age ; Had American Society Anesthesiologists ( ASA ) Physical Status Score IIII ; Were schedule undergo partial small large BR primary anastomosis ( perform completely laparotomy ) ; biliaryenteric RouxenY anastomosis surgery ; BMI ( kg/m^2 ) index≥15 ≤30 ; Understood procedure , agree participate study program , voluntarily sign informed consent form . Had complete bowel obstruction ; Were schedule total colectomy ; Were schedule ileal pouchanal anastomosis ; Were schedule colostomy , ileostomy ; Had history gastrectomy , total colectomy , gastric bypass , short bowel syndrome , multiple previous abdominal surgery ; Had clinically significant laboratory abnormality screen ( : ALT , AST 2 time upper limit normal value ; Cr great 1.2 time upper normal limit , accord center study normal value range ) ; Applied intravenous epidural postoperative analgesia pump ; Bowel preparation meet requirement ; Were allergy component investigational drug ( allantoin , metronidazole , dexamethasone ) ; Had use illicit drug abuse alcohol ; Had history illness , behavior ( e.g. , depression , psychosis ) opinion investigator might confound result study pose additional risk participate study ; Women pregnant , woman childbearing potential use method birth control ; Had participate another clinical drug trial within last 3 month ; Were agree participate clinical trial investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Ileus</keyword>
	<keyword>Intestinal Obstruction</keyword>
	<keyword>Intestinal Diseases</keyword>
	<keyword>Gastrointestinal Diseases</keyword>
	<keyword>Digestive System Diseases</keyword>
</DOC>